Drug Dosing in the Critically Ill Obese Patient

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Unfortunately, research related to drug dosing in overweight and obese patients has not kept pace with studies concerning the epidemiology and complications of obesity. The pivotal trials leading to drug approval typically include relatively few patients with extremes of weight relative to height. They usually focus on patients in non-ICU settings, and in some cases specifically exclude patients beyond a predefined weight. Furthermore, when the results of clinical trials are reported, patient weights are usually expressed in terms of summary statistics. Although patient weight is often the focus of discussions of drugs administered using weight-based dosing regimens, other factors such as height and body composition must be taken into account. As much as possible and practical, the way in which weight is estimated, measured, recorded, and utilized for drug dosing should be standardized to reduce variability that might lead to dosing errors.

Original languageEnglish (US)
Title of host publicationCritical Care Management of the Obese Patient
PublisherWiley-Blackwell
Pages195-207
Number of pages13
ISBN (Print)9780470655900
DOIs
StatePublished - Apr 19 2012

Fingerprint

Critical Illness
Weights and Measures
Pharmaceutical Preparations
Drug Approval
Body Composition
Epidemiology
Obesity
Clinical Trials
Research

Keywords

  • Adverse drug events
  • Critical care
  • Dosing
  • Drugs
  • Obesity
  • Pharmacokinetics
  • Size descriptors
  • Weight

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Erstad, B. L. (2012). Drug Dosing in the Critically Ill Obese Patient. In Critical Care Management of the Obese Patient (pp. 195-207). Wiley-Blackwell. https://doi.org/10.1002/9781119962083.ch22

Drug Dosing in the Critically Ill Obese Patient. / Erstad, Brian L.

Critical Care Management of the Obese Patient. Wiley-Blackwell, 2012. p. 195-207.

Research output: Chapter in Book/Report/Conference proceedingChapter

Erstad, BL 2012, Drug Dosing in the Critically Ill Obese Patient. in Critical Care Management of the Obese Patient. Wiley-Blackwell, pp. 195-207. https://doi.org/10.1002/9781119962083.ch22
Erstad BL. Drug Dosing in the Critically Ill Obese Patient. In Critical Care Management of the Obese Patient. Wiley-Blackwell. 2012. p. 195-207 https://doi.org/10.1002/9781119962083.ch22
Erstad, Brian L. / Drug Dosing in the Critically Ill Obese Patient. Critical Care Management of the Obese Patient. Wiley-Blackwell, 2012. pp. 195-207
@inbook{cad30028a1fc45fa8af1c79f6f4ec2cd,
title = "Drug Dosing in the Critically Ill Obese Patient",
abstract = "Unfortunately, research related to drug dosing in overweight and obese patients has not kept pace with studies concerning the epidemiology and complications of obesity. The pivotal trials leading to drug approval typically include relatively few patients with extremes of weight relative to height. They usually focus on patients in non-ICU settings, and in some cases specifically exclude patients beyond a predefined weight. Furthermore, when the results of clinical trials are reported, patient weights are usually expressed in terms of summary statistics. Although patient weight is often the focus of discussions of drugs administered using weight-based dosing regimens, other factors such as height and body composition must be taken into account. As much as possible and practical, the way in which weight is estimated, measured, recorded, and utilized for drug dosing should be standardized to reduce variability that might lead to dosing errors.",
keywords = "Adverse drug events, Critical care, Dosing, Drugs, Obesity, Pharmacokinetics, Size descriptors, Weight",
author = "Erstad, {Brian L}",
year = "2012",
month = "4",
day = "19",
doi = "10.1002/9781119962083.ch22",
language = "English (US)",
isbn = "9780470655900",
pages = "195--207",
booktitle = "Critical Care Management of the Obese Patient",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Drug Dosing in the Critically Ill Obese Patient

AU - Erstad, Brian L

PY - 2012/4/19

Y1 - 2012/4/19

N2 - Unfortunately, research related to drug dosing in overweight and obese patients has not kept pace with studies concerning the epidemiology and complications of obesity. The pivotal trials leading to drug approval typically include relatively few patients with extremes of weight relative to height. They usually focus on patients in non-ICU settings, and in some cases specifically exclude patients beyond a predefined weight. Furthermore, when the results of clinical trials are reported, patient weights are usually expressed in terms of summary statistics. Although patient weight is often the focus of discussions of drugs administered using weight-based dosing regimens, other factors such as height and body composition must be taken into account. As much as possible and practical, the way in which weight is estimated, measured, recorded, and utilized for drug dosing should be standardized to reduce variability that might lead to dosing errors.

AB - Unfortunately, research related to drug dosing in overweight and obese patients has not kept pace with studies concerning the epidemiology and complications of obesity. The pivotal trials leading to drug approval typically include relatively few patients with extremes of weight relative to height. They usually focus on patients in non-ICU settings, and in some cases specifically exclude patients beyond a predefined weight. Furthermore, when the results of clinical trials are reported, patient weights are usually expressed in terms of summary statistics. Although patient weight is often the focus of discussions of drugs administered using weight-based dosing regimens, other factors such as height and body composition must be taken into account. As much as possible and practical, the way in which weight is estimated, measured, recorded, and utilized for drug dosing should be standardized to reduce variability that might lead to dosing errors.

KW - Adverse drug events

KW - Critical care

KW - Dosing

KW - Drugs

KW - Obesity

KW - Pharmacokinetics

KW - Size descriptors

KW - Weight

UR - http://www.scopus.com/inward/record.url?scp=84886843531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886843531&partnerID=8YFLogxK

U2 - 10.1002/9781119962083.ch22

DO - 10.1002/9781119962083.ch22

M3 - Chapter

AN - SCOPUS:84886843531

SN - 9780470655900

SP - 195

EP - 207

BT - Critical Care Management of the Obese Patient

PB - Wiley-Blackwell

ER -